STEVEN KAPPES, is Center Director of the Roman L. Hruska U.S. Meat Animal Research Center (MARC) of the U.S. Department of Agriculture-Agricultural Research Service (ARS), in Clay Center, Nebraska. Before receiving his Ph.D. in Animal Science (Molecular Biology and Reproduction) from the University of Missouri-Columbia in 1992, he worked for ARS at MARC for six years as a Cattle Operations Assistant Manager. After earning his Ph.D., Dr. Kappes started his professional career at MARC as a Research Physiologist. In 1999, he joined the ARS Animal Production, Product Value, and Safety unit of the National Program Staff in Beltsville, Maryland.

HARRIS LEWIN, is a Professor in the Department of Animal Sciences at the University of Illinois, Urbana-Champaign. Dr. Lewin’s laboratory currently is focusing on three research areas, including the molecular characterization of the bovine major histocompatibility complex (MHC), the genetic and immunologic mechanisms of resistance and susceptibility to bovine leukemia virus (BLV) infection and disease progression, and gene mapping in cattle, with an emphasis on comparative mapping and mapping genes controlling economically important traits. Over the past five years his laboratory has developed a 300 marker linkage map of the bovine genome. Presently, Dr. Lewin and his colleagues are beginning to expand the map, with “expressed sequence tags,” or ESTs.

STEPHEN O’BRIEN, is Chief of the Laboratory of Genomic Diversity and head of the Section of Genetics at the National Cancer Institute (NCI). Dr. O’Brien came to National Institutes of Health as a postdoctoral fellow and designed a program based on mammalian somatic cell genetics. He is co-Chair of the International Committee on Comparative Gene Mapping and Editor of Genetic Maps. The central focus of Dr. O’Brien’s laboratory research concerns the collaborative interaction of mammalian cellular genes operative in concordant evolutionary descent of the immune system, retroviruses, and cancer onset. The purpose of these investigations is to determine the comparative mammalian genetic principles that participate in these processes.

ROGER WYSE, is Managing Director of Burrill & Company, which sponsors and manages a family of venture capital funds. Dr. Wyse has more than 27 years of experience as an internationally recognized scientist and was previously an administrator at Rutgers University and the University of Wisconsin, Madison, where he was Dean of the College of Agricultural and Life Sciences. Dr. Wyse received a Ph.D. in plant physiology from Michigan State University and a B.S. in agronomy from The Ohio State University. He served as co-CEO of Third Wave AgBio, which offers animal and plant genetics assays, was founding President and CEO of AniGenics, a fully integrated animal genomics company, and serves on the Boards of Directors of AniGenics and E-Markets.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement